STAPHYLOCOCCUS AUREUS (MRSA) INFEKSIYALARI: TARQALISH, VIRULENTLIK OMILLARI VA DAVOLASH MUAMMOLARI
Main Article Content
Аннотация:
Staphylococcus aureus, xususan metitsillin-rezistent S. aureus (MRSA) turlarining infeksiyalari global sog‘liqni saqlash tizimi uchun jiddiy xavf hisoblanadi. MRSA infektsiyalari nafaqat hamshiralik va shifoxona muhitida tarqaladi, balki jamiyat ichida ham sezilarli darajada uchraydi, bu esa davolashni murakkablashtiradi va antibiotik qarshilikning keng tarqalishiga olib keladi. Infeksiyaning virulentlik omillari orasida toksinlar, biofilm hosil qilish qobiliyati, adhesinlar va immuntizimga qarshi mexanizmlar muhim rol o‘ynaydi. MRSA infektsiyalari teri va yumshoq to‘qima infektsiyalari, pnevmoniya, sepsis va endokardit kabi jiddiy klinik ko‘rinishlarga sabab bo‘lishi mumkin. Davolash muammolari antibiotik qarshilik darajasi yuqori bo‘lgani sababli cheklangan dorivor imkoniyatlar, dozalash murakkabligi va bemorning umumiy holati bilan bog‘liq. Maqolada MRSA infektsiyalarining epidemiologiyasi, virulentlik mexanizmlari, klinik ko‘rinishlari, diagnostik yondashuvlar va zamonaviy davolash strategiyalari ilmiy asoslangan tarzda tahlil qilinadi. Shuningdek, infeksiya tarqalishini oldini olish va antibiotik qarshilikni kamaytirishga qaratilgan profilaktik va nazorat choralari ham muhokama qilinadi.
Article Details
Как цитировать:
Библиографические ссылки:
Lowy, F.D. Staphylococcus aureus infections. New England Journal of Medicine, 1998, vol. 339, pp. 520–532.
Chambers, H.F., & Deleo, F.R. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nature Reviews Microbiology, 2009, vol. 7, pp. 629–641.
David, M.Z., & Daum, R.S. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences. Clinical Microbiology Reviews, 2010, vol. 23(3), pp. 616–687.
Peacock, S.J., & Paterson, G.K. Mechanisms of methicillin resistance in Staphylococcus aureus. Annual Review of Biochemistry, 2015, vol. 84, pp. 109–131.
Deurenberg, R.H., & Stobberingh, E.E. The evolution of Staphylococcus aureus. Infection, Genetics and Evolution, 2008, vol. 8(6), pp. 747–763.
Turner, N.A., et al. Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research. Nature Reviews Microbiology, 2019, vol. 17, pp. 203–218.
Liu, C., et al. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clinical Infectious Diseases, 2011, vol. 52(3), pp. e18–e55.
Otter, J.A., et al. Transmission of MRSA in hospitals: current perspectives. Journal of Hospital Infection, 2013, vol. 85(4), pp. 235–246.
Chambers, H.F. Methicillin-resistant Staphylococcus aureus. New England Journal of Medicine, 2001, vol. 344, pp. 1425–1431.
Köck, R., et al. The epidemiology of MRSA in Europe. The Lancet Infectious Diseases, 2010, vol. 10(8), pp. 525–536.
Tattevin, P., et al. Invasive MRSA infections: clinical features and management. Clinical Microbiology and Infection, 2014, vol. 20, pp. 43–51.
Shorr, A.F., et al. Epidemiology, treatment, and outcomes of MRSA infections. Current Opinion in Infectious Diseases, 2014, vol. 27, pp. 121–127.
